Trials / Completed
CompletedNCT03975140
The Preventive Value of Acupoint Sensitization Based on Stable Angina Pectoris
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 202 (actual)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- All
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study, taking stable angina pectoris as a research carrier, aims to explore the preventive value of acupoint sensitization by conducting a double-blind multi-center randomized controlled trial to compare the effect of stimulating acupoints with different sensitivity on the prevention of angina pectoris. After the inclusion of eligible patients, the pressure-pain threshold of disease-related acupoints will be detected by using Von Frey detector. Then, the patients will be randomly divided into experimental group and control group. The patients in experimental group will be given acupoints pressure on the five acupoints with the lowest pressure-pain threshold, while the patients in control group will be given acupoints pressure on the five acupoints with the five acupoints with the highest pressure-pain threshold. The two groups will be treated with acupoints pressure 12 times within 4 weeks. The patients will be evaluated three times at baseline, the end of treatment and four weeks after the end of treatment respectively, including angina attack frequency, CCS classification and SAQ score.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hypersensitive acupoint group | The first five acupoints in the sensitization sequence were pressed using the traditional Chinese medicine acupoint pressing technique, and each acupoint was pressed for two minutes. |
| PROCEDURE | Hyposensitive acupoint group | The last five acupoints in the sensitization sequence were pressed using the traditional Chinese medicine acupoint pressing technique, and each acupoint was pressed for two minutes. |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2021-02-22
- Completion
- 2021-02-28
- First posted
- 2019-06-05
- Last updated
- 2021-03-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03975140. Inclusion in this directory is not an endorsement.